Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)
- Conditions
- Clinically Isolated SyndromeMultiple Sclerosis
- Registration Number
- NCT03541226
- Lead Sponsor
- University Hospital, Lille
- Brief Summary
The purpose of this study is to develop tools to detect, measure, monitor and predict axonal damage in the course of CIS and during Multiple sclerosis (MS), in order to be able to consider as early as possible an adaptation of the background treatment in patients with MS. patients with radiological criteria of poor long-term clinical course.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 134
- Any patient who has had a CIS of less than 4 months (+/- 15 days), with at least 1 inflammatory lesion on his initial brain MRI or with normal brain MRI associated with the presence of oligoclonal bands in the CSF,
- Atypical CIS for a first relapse of multiple sclerosis (extensive myelitis, bilateral retrobulbar optic neuritis immediately)
- CIS dating more than 4 months (+/- 15 days)
- Corticotherapy in the last 4 weeks
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method severity of the disease defined by Expanded Disability Status Scale (EDSS) ≥ 2.0 At 5 years
- Secondary Outcome Measures
Name Time Method Occurrence of a handicap objectified by the Multiple Sclerosis Functional Composite(MSFC) At 5 years variation of parameters measuring axonal pain / degeneration in MRI At 5 years variation of parameters measuring axonal pain / degeneration in OCT At 5 years Occurrence of progression of the EDSS (Expanded Disability Status Scale) score At 5 years The scale evaluated the pyramidal, cerebellar, sensory, visual and mental functions . These make it possible to obtain a quotation between 0 and 10. The walk is called "normal" from 0 to 3.5. The walk is hampered from 4 and impossible from 7.5. The coast of 10 corresponds to the death of the patient.
This measure differentiates two groups: severe EDSS and non-severe EDSS group,Occurrence of a second push At 5 years
Trial Locations
- Locations (1)
Hôpital Roger Salengro, CHRU de Lille
🇫🇷Lille, France